Targeted Drug Delivery, Imaging And Therapy

About Us
About Perkins

Since 1998, the Perkins has grown to become one of the nation's leading adult medical research centres, where a close-knit team of more than 450 research and clinical staff work together to defeat the major diseases that impact our community.
Research
Research

Perkins researchers focus on some of the major diseases that affect our community. In particular we focus on cancer, diabetes, heart disease and neuromuscular diseases.
Support the Perkins
Support the Perkins

Your support will help us to deliver a healthier future through medical breakthroughs, new treatments and fostering the next generation of scientific talent.
Get Involved
Get Involved

You can support Perkins work in many different ways. From participating in an event, to attending a workshop in the BioDiscovery Centre, to volunteering your time, or supporting our research, we welcome your involvement.
Donate

Home » Research » Labs » Cancer Program » Targeted Drug Delivery, Imaging And Therapy – Overview

Home > Research > Labs > Cancer Program > TARGETED DRUG DELIVERY, IMAGING AND THERAPY

RESEARCH OVERVIEW

We focus on developing strategies to specifically target diseases such as cancer and atherosclerosis for diagnostic imaging and local therapeutic interventions.

Cancer and cardiovascular disease
Fibro-inflammatory cells and extracellular matrix
Tissue homing peptides and targeted delivery
In vivo imaging
Targeted therapy
Nanotechnology

Our goal is to identify diagnostic and therapeutic overlaps between different types of chronic fibro-inflammatory diseases such as cancer, atherosclerotic disease and other tissue fibrosis.

Associate Professor Juliana Hamzah

Targeted Drug Delivery, Imaging and Therapy (Theme Head - Therapeutic Targeting)

Perkins researcher elected as prestigious new Fellow

Professor Alistair Forrest from the Harry Perkins Institute of Medical Research has been selected alongside 27 new Fellows of the Australian Academy of Health and Medical Sciences. Professor Forrest is internationally regarded for his pioneering work, which has been driving forward our understanding of human diseases and the complex behaviour…

Read More

Molecular machines stop cancer’s clock

Head of the laboratory for Synthetic Biology and Drug Discovery, Professor Oliver Rackham, says cancer cells grow uncontrollably whereas normal cells limit their growth. “A normal cell grows for just the right amount of time that is required for us to develop and maintain our bodies. “They control their growth with…

Read More

Stem cell reprogramming mystery clarified by new findings

In a study, published in Cell Stem Cell, researchers from the University of Western Australia, the Harry Perkins Institute of Medical Research, and Monash University describe key drivers of the process by which cells from mature tissues of the body, such as skin, can be deliberately converted into stem cells that…

Read More